Skip to main navigation Skip to search Skip to main content

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

  • Christina I. Tsien
  • , Stephanie L. Pugh
  • , Adam P. Dicker
  • , Jeffrey J. Raizer
  • , Martha M. Matuszak
  • , Enrico C. Lallana
  • , Jiayi Huang
  • , Ozer Algan
  • , Nimisha Deb
  • , Lorraine Portelance
  • , John L. Villano
  • , John T. Hamm
  • , Kevin S. Oh
  • , Arif N. Ali
  • , Michelle M. Kim
  • , Scott M. Lindhorst
  • , Minesh P. Mehta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science